Rasmussen T, Mao X, Forster S, Larsen S, Von Munchow A, Tranaes K
    
    
    Microbiome. 2024; 12(1):119.
  
  
    PMID: 38951925
    
          PMC: 11218093.
    
          DOI: 10.1186/s40168-024-01820-1.
      
 
                                  
  
    DiCandia M, Edwards A, Alcaraz Y, Monteiro M, Lee C, Vargas Cuebas G
    
    
    PLoS Pathog. 2024; 20(5):e1012224.
  
  
    PMID: 38739653
    
          PMC: 11115286.
    
          DOI: 10.1371/journal.ppat.1012224.
      
 
                                  
  
    Hosseini M, Huang J, Williams M, Gonzalez G, Jiang X, Falkinham 3rd J
    
    
    Microorganisms. 2024; 12(1).
  
  
    PMID: 38257910
    
          PMC: 10818310.
    
          DOI: 10.3390/microorganisms12010083.
      
 
                                  
  
    Dailey K, Small J, Pullan J, Winfree S, Vance K, Orr M
    
    
    PLoS One. 2023; 18(11):e0289183.
  
  
    PMID: 37963142
    
          PMC: 10645340.
    
          DOI: 10.1371/journal.pone.0289183.
      
 
                                  
  
    Rizvi A, Vargas-Cuebas G, Edwards A, DiCandia M, Carter Z, Lee C
    
    
    Infect Immun. 2023; 91(10):e0031923.
  
  
    PMID: 37754683
    
          PMC: 10580938.
    
          DOI: 10.1128/iai.00319-23.
      
 
                              
              
                              
                                      
  Butyrate enhances  sporulation .
  
    Baldassare M, Bhattacharjee D, Coles J, Nelson S, McCollum C, Seekatz A
    
    
    J Bacteriol. 2023; 205(9):e0013823.
  
  
    PMID: 37655912
    
          PMC: 10521354.
    
          DOI: 10.1128/jb.00138-23.
      
 
                                          
                                                          
  2'-Fucosyllactose inhibits proliferation of  ATCC 43599 in the CDi-screen, an  model simulating  infection.
  
    Wiese M, Schuren F, Smits W, Kuijper E, Ouwens A, Heerikhuisen M
    
    
    Front Cell Infect Microbiol. 2022; 12:991150.
  
  
    PMID: 36389156
    
          PMC: 9650113.
    
          DOI: 10.3389/fcimb.2022.991150.
      
 
                                          
                                                          
  Long-Term Lactulose Administration Improves Dysbiosis Induced by Antibiotic and  in the PathoGut SHIME Model.
  
    Calatayud M, Duysburgh C, Van den Abbeele P, Franckenstein D, Kuchina-Koch A, Marzorati M
    
    
    Antibiotics (Basel). 2022; 11(11).
  
  
    PMID: 36358119
    
          PMC: 9686563.
    
          DOI: 10.3390/antibiotics11111464.
      
 
                                          
                                                          
  Characterization of the Effects of Candida Gastrointestinal Colonization on Clostridioides difficile Infection in a Murine Model.
  
    Romo J, Kumamoto C
    
    
    Methods Mol Biol. 2022; 2542:271-285.
  
  
    PMID: 36008672
    
    
          DOI: 10.1007/978-1-0716-2549-1_20.
      
 
                                          
                                                          
  Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis.
  
    Pike C, Tam J, Melnyk R, Theriot C
    
    
    Infect Immun. 2022; 90(8):e0015322.
  
  
    PMID: 35862710
    
          PMC: 9387233.
    
          DOI: 10.1128/iai.00153-22.
      
 
                                          
                                                          
  Response Regulator CD1688 Is a Negative Modulator of Sporulation in Clostridioides difficile.
  
    Kempher M, Morris S, Shadid T, Menon S, Ballard J, West A
    
    
    J Bacteriol. 2022; 204(8):e0013022.
  
  
    PMID: 35852332
    
          PMC: 9380558.
    
          DOI: 10.1128/jb.00130-22.
      
 
                                          
                                                          
  An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis.
  
    Cubillos-Ruiz A, Alcantar M, Donghia N, Cardenas P, Avila-Pacheco J, Collins J
    
    
    Nat Biomed Eng. 2022; 6(7):910-921.
  
  
    PMID: 35411114
    
    
          DOI: 10.1038/s41551-022-00871-9.
      
 
                                          
                                                          
  Efficacy of EPA-registered disinfectants against two human norovirus surrogates and Clostridioides difficile endospores.
  
    Huang J, Park G, Jones R, Fraser A, Vinje J, Jiang X
    
    
    J Appl Microbiol. 2022; 132(6):4289-4299.
  
  
    PMID: 35279925
    
          PMC: 9119914.
    
          DOI: 10.1111/jam.15524.
      
 
                                          
                                                          
  Flagellum and toxin phase variation impacts intestinal colonization and disease development in a mouse model of  infection.
  
    Trzilova D, Warren M, Gadda N, Williams C, Tamayo R
    
    
    Gut Microbes. 2022; 14(1):2038854.
  
  
    PMID: 35192433
    
          PMC: 8890394.
    
          DOI: 10.1080/19490976.2022.2038854.
      
 
                                          
                                                          
  Identification of novel, cryptic  species isolates from environmental samples collected from diverse geographical locations.
  
    Williamson C, Stone N, Nunnally A, Roe C, Vazquez A, Lucero S
    
    
    Microb Genom. 2022; 8(2).
  
  
    PMID: 35166655
    
          PMC: 8942030.
    
          DOI: 10.1099/mgen.0.000742.
      
 
                                          
                                                          
  Identification of ClpP Dual Isoform Disruption as an Antisporulation Strategy for Clostridioides difficile.
  
    Bishop C, Shadid T, Lavey N, Kempher M, Ballard J, Duerfeldt A
    
    
    J Bacteriol. 2021; 204(2):e0041121.
  
  
    PMID: 34807726
    
          PMC: 8846446.
    
          DOI: 10.1128/JB.00411-21.
      
 
                                          
                                                          
  In Vitro and In Vivo Anti- Effect of a Probiotic  Strain.
  
    Islam M, Seo H, Redwan A, Kim S, Lee S, Siddiquee M
    
    
    J Microbiol Biotechnol. 2021; 32(1):46-55.
  
  
    PMID: 34675143
    
          PMC: 9628829.
    
          DOI: 10.4014/jmb.2107.07057.
      
 
                                          
                                                          
  2'FL and LNnT Exert Antipathogenic Effects against  ATCC 9689 In Vitro, Coinciding with Increased Levels of  and/or Secondary Bile Acids.
  
    Vigsnaes L, Ghyselinck J, Van den Abbeele P, McConnell B, Moens F, Marzorati M
    
    
    Pathogens. 2021; 10(8).
  
  
    PMID: 34451391
    
          PMC: 8402123.
    
          DOI: 10.3390/pathogens10080927.
      
 
                                          
                                                          
  Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection.
  
    Chen P, Zeng J, Liu Z, Thaker H, Wang S, Tian S
    
    
    Nat Commun. 2021; 12(1):3748.
  
  
    PMID: 34145250
    
          PMC: 8213806.
    
          DOI: 10.1038/s41467-021-23878-3.
      
 
                                          
                                                          
  Methods and Techniques to Facilitate the Development of  NT as an Effective, Therapeutic Oncolytic Bacteria.
  
    Dailey K, Jacobson R, Johnson P, Woolery T, Kim J, Jansen R
    
    
    Front Microbiol. 2021; 12:624618.
  
  
    PMID: 33854487
    
          PMC: 8039391.
    
          DOI: 10.3389/fmicb.2021.624618.